DMAC Net Income Growth
Diamedica Therapeutics Inc · Net Income Growth
DMAC Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.91%period ending
DMAC TTM Net Income YoY % (-274.09% → -26.91%)
Year-over-year change
High-resolution chart · PNG
DMAC net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -26.9135% | |
| -30.0037% | |
| -34.0452% | |
| -47.0905% | |
| -48.6283% | |
| -40.1869% | |
| -26.1235% | |
| -20.7779% | |
| -20.1884% | |
| -24.7409% | |
| -41.7154% | |
| -36.4437% | |
| -22.0985% | |
| -14.5571% | |
| -0.618% | |
| 9.4528% | |
| 5.0878% | |
| 0.0815% | |
| -10.576% | |
| -37.5899% | |
| -45.4055% | |
| -37.3346% | |
| -15.4287% | |
| -14.5272% | |
| -34.4035% | |
| -16.8682% | |
| -85.7168% | |
| -63.22% | |
| -21.392% | |
| -137.8973% | |
| -34.6009% | |
| -53.2334% | |
| -61.1871% | |
| -10.6189% | |
| -90.5157% | |
| -60.4472% | |
| -134.5336% | |
| -128.0415% | |
| -49.8162% | |
| -30.3258% | |
| 33.9356% | |
| 57.5858% | |
| 69.4877% | |
| 66.9452% | |
| 58.2357% | |
| 50.8085% | |
| 33.944% | |
| 41.8751% | |
| 44.7356% | |
| 38.0614% | |
| 25.5122% | |
| -3.4728% | |
| -29.6248% | |
| -54.2531% | |
| -45.9455% | |
| -30.7813% | |
| -33.2836% | |
| -33.7546% | |
| -66.2513% | |
| -144.9658% | |
| -156.983% | |
| -150.6468% | |
| -79.8078% | |
| -35.6142% | |
| -9.1719% | |
| 10.3396% | |
| -20.9705% | |
| 6.5604% | |
| -14.1175% | |
| -3.5323% | |
| 15.6563% | |
| -22.4275% | |
| -20.6134% | |
| -201.2671% | |
| -189.9762% | |
| -182.3932% | |
| -220.0794% | |
| -118.5076% | |
| -274.0913% |